News

TASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cells

The Kannouche team contributed to this study, published in Cancer Cell (2026), reporting the results of the ICARUS-LUNG01 Phase II trial: Efficacy, Safety, and Biomarker Analysis of Datopotamab Deruxtecan in Advanced Non-Small Cell Lung Cancer. The study evaluates the clinical activity, safety profile, and predictive biomarkers associated with datopotamab deruxtecan in patients with advanced non-small cell lung cancer.

Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study

DES BUTS CONTRE LE CANCER

DES BUTS CONTRE LE CANCER – Des stars du football se mobilisent lors d’un match au profit de Gustave Roussy

16th 3R meeting

16th edition of the French 3R meeting “Replication, Recombination, Repair” We are happy to announce the opening of registrations for the 16th

Seminar | Matinée de l’Intégrité du Génome

Seminar « Functional Genomics of Microsatellite Unstable Tumors and Therapeutic Target Discovery » by Gabriele Picco (Sanger Institute) 11:00 05/12/2025 at Roger Monier.

Clara Basto, prix Peters at the « Journées JJCC de la Fonation ARC »

Clara Basto, PhD student of the team of Gerard Mazón/Eric Le Cam under the supervision of Pauline Dupaigne has been awarded the « Prix coup de coeur du Jury » for her talk during the 29th « Journées Jeunes Chercheurs de la Fondation ARC ».